ACTIVATION OF CELL-GROWTH INHIBITOR BY ECTOPROTEIN KINASE-MEDIATED PHOSPHORYLATION IN TRANSFORMED MOUSE FIBROBLASTS

被引:30
作者
FRIEDBERG, I [1 ]
BELZER, I [1 ]
OGEDPLESZ, O [1 ]
KUEBLER, D [1 ]
机构
[1] GERMAN CANC RES CTR, DKFZ, DIV PATHOCHEM, D-69120 HEIDELBERG, GERMANY
关键词
D O I
10.1074/jbc.270.35.20560
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Our previous studies have shown that exogenous ATP induces cell growth inhibition in transformed mouse fibroblasts, 3T6 cells, whereas the growth of their nontransformed counterparts, Swiss 3T3 cells, is only slightly affected. In this study a similar selective, ATP-induced growth inhibition was found in Balb/c SV40-3T3 cells and in primary cultures of adenovirus-transformed murine fibroblasts. The inhibitory activity was found in the conditioned media of ATP-treated cultures. Several lines of evidence have shown that ectoprotein kinase (ecto-PK) plays a major role in the ATP-induced growth inhibition. (a) There is a good correlation between the activity of ecto-PK and the ability of ATP to induce cell growth inhibition. (b) The removal of the ecto-PK from the cell surface prevents the ATP-induced growth inhibition. (c) Addition of the removed enzyme to the cell culture reconstitutes the ability of ATP to induced growth inhibition. (d) Serum-containing, or serum-free, conditioned media from untreated cultures gain an inhibitory activity after their phosphorylation, and dephosphorylation of conditioned media from ATP-treated cultures results in the loss of the inhibitory activity. (e) Growth medium by itself does not inhibit cell proliferation after its phosphorylation. The findings described in d and e indicate, as well, that the ATP-induced growth inhibitor is produced by the cells. The putative inhibitor was found to be a protein, with an apparent molecular mass of 13 kDa. The selectivity of the inhibition for transformed cells is due to the higher level of ecto-PK in these cells, as well as to their higher susceptibility to the inhibitor, as compared with their nontransformed counterparts.
引用
收藏
页码:20560 / 20567
页数:8
相关论文
共 71 条
  • [1] THE MULTIDRUG RESISTANCE (MDR1) GENE-PRODUCT FUNCTIONS AS AN ATP CHANNEL
    ABRAHAM, EH
    PRAT, AG
    GERWECK, L
    SENEVERATNE, T
    ARCECI, RJ
    KRAMER, R
    GUIDOTTI, G
    CANTIELLO, HF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (01) : 312 - 316
  • [2] AHARONI D, 1991, J BASIC CLIN PHYSL P, V3, pA3
  • [3] BELZER I, 1984, ISRAEL J MED SCI, V20, P483
  • [4] ATP-RESISTANT VARIANTS OF TRANSFORMED MOUSE FIBROBLASTS
    BELZER, I
    FRIEDBERG, I
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1989, 140 (03) : 524 - 529
  • [5] RELEASE OF ATP FROM HUMAN ERYTHROCYTES IN RESPONSE TO A BRIEF PERIOD OF HYPOXIA AND HYPERCAPNIA
    BERGFELD, GR
    FORRESTER, T
    [J]. CARDIOVASCULAR RESEARCH, 1992, 26 (01) : 40 - 47
  • [6] DISTRIBUTION AND ROLES OF PURINOCEPTOR SUBTYPES
    BURNSTOCK, G
    [J]. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 1991, 10 (05) : 917 - 930
  • [7] DIRECT EVIDENCE FOR ATP RELEASE FROM NON-ADRENERGIC, NON-CHOLINERGIC (PURINERGIC) NERVES IN GUINEA-PIG TAENIA-COLI AND BLADDER
    BURNSTOCK, G
    COCKS, T
    KASAKOV, L
    WONG, HK
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 49 (02) : 145 - 149
  • [8] PHYSIOLOGICAL AND PATHOLOGICAL ROLES OF PURINES - AN UPDATE
    BURNSTOCK, G
    [J]. DRUG DEVELOPMENT RESEARCH, 1993, 28 (03) : 195 - 206
  • [9] IS THERE A BASIS FOR DISTINGUISHING 2 TYPES OF P2-PURINOCEPTOR
    BURNSTOCK, G
    KENNEDY, C
    [J]. GENERAL PHARMACOLOGY, 1985, 16 (05): : 433 - 440
  • [10] BURNSTOCK G, 1972, PHARMACOL REV, V24, P509